Annual Net Income
-$151.58 M
+$84.98 M+35.92%
December 31, 2023
Summary
- As of February 8, 2025, FOLD annual net profit is -$151.58 million, with the most recent change of +$84.98 million (+35.92%) on December 31, 2023.
- During the last 3 years, FOLD annual net income has risen by +$125.27 million (+45.25%).
- FOLD annual net income is now -2208.27% below its all-time high of -$6.57 million, reached on December 31, 2009.
Performance
FOLD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$6.73 M
+$8.97 M+57.13%
September 30, 2024
Summary
- As of February 8, 2025, FOLD quarterly net profit is -$6.73 million, with the most recent change of +$8.97 million (+57.13%) on September 30, 2024.
- Over the past year, FOLD quarterly net income has increased by +$14.85 million (+68.81%).
- FOLD quarterly net income is now -120.42% below its all-time high of $32.96 million, reached on December 31, 2009.
Performance
FOLD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$104.69 M
+$14.85 M+12.42%
September 30, 2024
Summary
- As of February 8, 2025, FOLD TTM net profit is -$104.69 million, with the most recent change of +$14.85 million (+12.42%) on September 30, 2024.
- Over the past year, FOLD TTM net income has increased by +$68.92 million (+39.70%).
- FOLD TTM net income is now -2008.94% below its all-time high of -$4.96 million, reached on June 30, 2010.
Performance
FOLD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
FOLD Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.9% | +68.8% | +39.7% |
| 3 y3 years | +45.3% | +68.8% | +39.7% |
| 5 y5 years | +56.6% | +68.8% | +39.7% |
FOLD Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.5% | at high | +92.1% | at high | +62.7% |
| 5 y | 5-year | at high | +57.5% | at high | +92.5% | at high | +70.6% |
| alltime | all time | -2208.3% | +57.5% | -120.4% | +95.8% | -2008.9% | +76.3% |
Amicus Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.73 M(-57.1%) | -$104.69 M(-12.4%) |
| Jun 2024 | - | -$15.70 M(-67.6%) | -$119.54 M(-18.7%) |
| Mar 2024 | - | -$48.42 M(+43.1%) | -$147.07 M(-3.0%) |
| Dec 2023 | -$151.58 M(-35.9%) | -$33.84 M(+56.8%) | -$151.58 M(-12.7%) |
| Sep 2023 | - | -$21.58 M(-50.1%) | -$173.61 M(-6.3%) |
| Jun 2023 | - | -$43.23 M(-18.3%) | -$185.31 M(-9.3%) |
| Mar 2023 | - | -$52.93 M(-5.3%) | -$204.24 M(-13.7%) |
| Dec 2022 | -$236.57 M(-5.5%) | -$55.87 M(+67.8%) | -$236.57 M(-10.4%) |
| Sep 2022 | - | -$33.29 M(-46.4%) | -$263.98 M(-6.1%) |
| Jun 2022 | - | -$62.16 M(-27.1%) | -$280.99 M(+4.0%) |
| Mar 2022 | - | -$85.26 M(+2.4%) | -$270.06 M(+7.8%) |
| Dec 2021 | -$250.46 M(-9.5%) | -$83.28 M(+65.6%) | -$250.46 M(+5.0%) |
| Sep 2021 | - | -$50.29 M(-1.8%) | -$238.58 M(-5.4%) |
| Jun 2021 | - | -$51.23 M(-22.0%) | -$252.30 M(-0.5%) |
| Mar 2021 | - | -$65.66 M(-8.0%) | -$253.57 M(-8.4%) |
| Dec 2020 | -$276.85 M(-22.3%) | -$71.40 M(+11.5%) | -$276.85 M(-6.2%) |
| Sep 2020 | - | -$64.01 M(+21.9%) | -$295.18 M(+0.8%) |
| Jun 2020 | - | -$52.49 M(-41.0%) | -$292.98 M(-9.9%) |
| Mar 2020 | - | -$88.95 M(-0.9%) | -$325.04 M(-8.8%) |
| Dec 2019 | -$356.39 M(+2.1%) | -$89.73 M(+45.2%) | -$356.39 M(+3.4%) |
| Sep 2019 | - | -$61.81 M(-26.9%) | -$344.74 M(-22.0%) |
| Jun 2019 | - | -$84.55 M(-29.7%) | -$442.09 M(+5.4%) |
| Mar 2019 | - | -$120.30 M(+54.1%) | -$419.38 M(+20.2%) |
| Dec 2018 | -$349.00 M(+22.9%) | -$78.08 M(-50.9%) | -$348.99 M(+2.6%) |
| Sep 2018 | - | -$159.16 M(+157.4%) | -$340.12 M(+16.2%) |
| Jun 2018 | - | -$61.83 M(+23.9%) | -$292.62 M(+4.9%) |
| Mar 2018 | - | -$49.92 M(-27.9%) | -$278.93 M(-1.8%) |
| Dec 2017 | -$284.00 M(+42.0%) | -$69.21 M(-38.0%) | -$284.00 M(+3.9%) |
| Sep 2017 | - | -$111.67 M(+132.0%) | -$273.44 M(+31.2%) |
| Jun 2017 | - | -$48.14 M(-12.5%) | -$208.43 M(-1.4%) |
| Mar 2017 | - | -$54.99 M(-6.2%) | -$211.34 M(+5.6%) |
| Dec 2016 | -$200.04 M(+51.4%) | -$58.65 M(+25.7%) | -$200.04 M(+8.5%) |
| Sep 2016 | - | -$46.65 M(-8.6%) | -$184.29 M(+5.0%) |
| Jun 2016 | - | -$51.05 M(+16.8%) | -$175.44 M(+15.8%) |
| Mar 2016 | - | -$43.69 M(+1.9%) | -$151.52 M(+14.7%) |
| Dec 2015 | -$132.12 M(+91.7%) | -$42.90 M(+13.5%) | -$132.12 M(+19.6%) |
| Sep 2015 | - | -$37.80 M(+39.3%) | -$110.44 M(+23.0%) |
| Jun 2015 | - | -$27.13 M(+11.7%) | -$89.79 M(+16.2%) |
| Mar 2015 | - | -$24.29 M(+14.5%) | -$77.27 M(+12.1%) |
| Dec 2014 | -$68.93 M | -$21.22 M(+23.7%) | -$68.93 M(+15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | -$17.15 M(+17.3%) | -$59.94 M(+4.5%) |
| Jun 2014 | - | -$14.61 M(-8.3%) | -$57.38 M(-1.3%) |
| Mar 2014 | - | -$15.94 M(+30.3%) | -$58.12 M(-2.5%) |
| Dec 2013 | -$59.63 M(+22.2%) | -$12.24 M(-16.1%) | -$59.63 M(+3.9%) |
| Sep 2013 | - | -$14.59 M(-5.0%) | -$57.41 M(-2.9%) |
| Jun 2013 | - | -$15.35 M(-12.1%) | -$59.11 M(+11.3%) |
| Mar 2013 | - | -$17.46 M(+74.3%) | -$53.11 M(+8.9%) |
| Dec 2012 | -$48.78 M(+9.8%) | -$10.02 M(-38.5%) | -$48.78 M(+2.9%) |
| Sep 2012 | - | -$16.29 M(+74.4%) | -$47.43 M(+16.0%) |
| Jun 2012 | - | -$9.34 M(-28.9%) | -$40.90 M(-7.5%) |
| Mar 2012 | - | -$13.14 M(+51.7%) | -$44.20 M(-0.5%) |
| Dec 2011 | -$44.41 M(-19.2%) | -$8.66 M(-11.2%) | -$44.41 M(-12.6%) |
| Sep 2011 | - | -$9.76 M(-22.8%) | -$50.84 M(-9.9%) |
| Jun 2011 | - | -$12.64 M(-5.3%) | -$56.44 M(+2.4%) |
| Mar 2011 | - | -$13.35 M(-11.5%) | -$55.11 M(+0.3%) |
| Dec 2010 | -$54.94 M(+736.5%) | -$15.09 M(-1.8%) | -$54.94 M(+697.1%) |
| Sep 2010 | - | -$15.36 M(+35.7%) | -$6.89 M(+38.8%) |
| Jun 2010 | - | -$11.31 M(-14.1%) | -$4.96 M(-31.7%) |
| Mar 2010 | - | -$13.18 M(-140.0%) | -$7.27 M(+10.7%) |
| Dec 2009 | -$6.57 M(-83.3%) | $32.96 M(-345.4%) | -$6.57 M(-87.8%) |
| Sep 2009 | - | -$13.43 M(-1.4%) | -$53.67 M(+10.8%) |
| Jun 2009 | - | -$13.62 M(+9.2%) | -$48.42 M(+9.8%) |
| Mar 2009 | - | -$12.47 M(-11.9%) | -$44.10 M(+12.0%) |
| Dec 2008 | -$39.35 M(-4.4%) | -$14.15 M(+73.0%) | -$39.35 M(+6.4%) |
| Sep 2008 | - | -$8.18 M(-12.0%) | -$36.98 M(-5.4%) |
| Jun 2008 | - | -$9.29 M(+20.2%) | -$39.10 M(-0.3%) |
| Mar 2008 | - | -$7.73 M(-34.3%) | -$39.20 M(-4.8%) |
| Dec 2007 | -$41.17 M(-11.2%) | -$11.77 M(+14.3%) | -$41.17 M(+0.5%) |
| Sep 2007 | - | -$10.30 M(+9.7%) | -$40.98 M(-3.0%) |
| Jun 2007 | - | -$9.40 M(-3.1%) | -$42.26 M(-4.9%) |
| Mar 2007 | - | -$9.70 M(-16.3%) | -$44.45 M(-4.1%) |
| Dec 2006 | -$46.34 M(+132.0%) | -$11.59 M(+0.0%) | -$46.34 M(+16.6%) |
| Sep 2006 | - | -$11.59 M(0.0%) | -$39.75 M(+19.9%) |
| Jun 2006 | - | -$11.59 M(0.0%) | -$33.16 M(+24.8%) |
| Mar 2006 | - | -$11.59 M(+132.0%) | -$26.57 M(+33.0%) |
| Dec 2005 | -$19.97 M(+126.8%) | -$4.99 M(0.0%) | -$19.97 M(+33.3%) |
| Sep 2005 | - | -$4.99 M(0.0%) | -$14.98 M(+50.0%) |
| Jun 2005 | - | -$4.99 M(0.0%) | -$9.99 M(+100.0%) |
| Mar 2005 | - | -$4.99 M | -$4.99 M |
| Dec 2004 | -$8.81 M(+30.1%) | - | - |
| Dec 2003 | -$6.77 M | - | - |
FAQ
- What is Amicus Therapeutics annual net profit?
- What is the all time high annual net income for Amicus Therapeutics?
- What is Amicus Therapeutics annual net income year-on-year change?
- What is Amicus Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly net income year-on-year change?
- What is Amicus Therapeutics TTM net profit?
- What is the all time high TTM net income for Amicus Therapeutics?
- What is Amicus Therapeutics TTM net income year-on-year change?
What is Amicus Therapeutics annual net profit?
The current annual net income of FOLD is -$151.58 M
What is the all time high annual net income for Amicus Therapeutics?
Amicus Therapeutics all-time high annual net profit is -$6.57 M
What is Amicus Therapeutics annual net income year-on-year change?
Over the past year, FOLD annual net profit has changed by +$84.98 M (+35.92%)
What is Amicus Therapeutics quarterly net profit?
The current quarterly net income of FOLD is -$6.73 M
What is the all time high quarterly net income for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly net profit is $32.96 M
What is Amicus Therapeutics quarterly net income year-on-year change?
Over the past year, FOLD quarterly net profit has changed by +$14.85 M (+68.81%)
What is Amicus Therapeutics TTM net profit?
The current TTM net income of FOLD is -$104.69 M
What is the all time high TTM net income for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM net profit is -$4.96 M
What is Amicus Therapeutics TTM net income year-on-year change?
Over the past year, FOLD TTM net profit has changed by +$68.92 M (+39.70%)